Efficacy and Safety of Perampanel in Children with Drug-Resistant Focal-Onset Seizures: A Retrospective Review
Background: Epilepsy is one of the most common neurological disorders. Existing antiseizure medications (ASMs) are still unable to control seizures in one-third of these patients, making the discovery of antiseizure therapies with novel mechanisms of action a necessity. Aim of the Study: This study...
Saved in:
Main Authors: | Ahmed Elmardenly (Author), Zekra Aljehani (Author), Abdullah Tamim (Author), Anas Alyazidi (Author), Osama Muthaffar (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perampanel: New drug for treatment of refractory partial onset seizures
by: Santosh Kumar Singh, et al.
Published: (2014) -
Perampanel: New drug for treatment of refractory partial onset seizures
by: Santosh Kumar Singh, et al.
Published: (2014) -
Value of Perampanel as Adjunctive Treatment for Partial-Onset Seizures in Epilepsy: Cost-Effectiveness and Budget Impact Analysis
by: Donger Zhang, et al.
Published: (2021) -
Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
by: Jia-Qin Yi, et al.
Published: (2023) -
Induced atypical absence seizures during treatment with perampanel
by: Anna Duat Rodríguez, et al.
Published: (2019)